Following an inspection of its Bengaluru facility, Cipla has received 8 observations in Form 483 from the US Food and Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback